Plus Therapeutics Inc (NASDAQ:PSTV)
| 2.03 Delayed Data As of Feb 25 |  -0.10 / -4.69%Today’s Change | 1.78 Today|||52-Week Range 22.89 | -15.42% Year-to-Date |
Latest PSTV News | Press Releases
No recent news for Plus Therapeutics Inc.
Today’s Trading
| Previous close | 2.13 |
| Today’s open | 2.07 |
| Day’s range | 2.02 - 2.13 |
| Volume | 46,766 |
| Average volume (3 months) | 360,135 |
| Market cap | $8.0M |
Data as of 3:57pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | +78.79% |
| Earnings growth (this year) | +71.23% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +36.52% |
| P/E ratio | NM |
| Price/Sales | 0.69 |
| Price/Book | 0.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DYNTDynatronics Corp | +0.00 | +0.27% |
| AVGRAvinger Inc | -0.04 | -6.60% |
| MYOSMYOS RENS Technology... | -0.04 | -3.52% |
| NURONeuroMetrix Inc | -0.20 | -7.60% |
Data as of 4:00pm ET, 02/25/2020
Financials
| Next reporting date | March 9, 2020 |
| EPS forecast (this quarter) | -$5.72 |
| Annual revenue (last year) | $3.7M |
| Annual profit (last year) | -$15.1M |
| Net profit margin | -411.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
